294 related articles for article (PubMed ID: 28179177)
41. The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma.
Chen J; Fan W; Gu H; Wang Y; Liu Y; Chen X; Ren S; Wang Z
Acta Radiol; 2021 Jul; 62(7):959-965. PubMed ID: 32727213
[TBL] [Abstract][Full Text] [Related]
42. Apparent diffusion coefficient in differentiation of pediatric posterior fossa tumors.
Zitouni S; Koc G; Doganay S; Saracoglu S; Gumus KZ; Ciraci S; Coskun A; Unal E; Per H; Kurtsoy A; Kontas O
Jpn J Radiol; 2017 Aug; 35(8):448-453. PubMed ID: 28550357
[TBL] [Abstract][Full Text] [Related]
43. Cervical lymphadenopathy: can the histogram analysis of apparent diffusion coefficient help to differentiate between lymphoma and squamous cell carcinoma in patients with unknown clinical primary tumor?
Vidiri A; Minosse S; Piludu F; Pellini R; Cristalli G; Kayal R; Carlino G; Renzi D; Covello R; Marzi S
Radiol Med; 2019 Jan; 124(1):19-26. PubMed ID: 30196522
[TBL] [Abstract][Full Text] [Related]
44. Characterization of hemangioblastomas of spinal nerves.
Gläsker S; Berlis A; Pagenstecher A; Vougioukas VI; Van Velthoven V
Neurosurgery; 2005 Mar; 56(3):503-9; discussion 503-9. PubMed ID: 15730575
[TBL] [Abstract][Full Text] [Related]
45. Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T.
Park GE; Jee WH; Lee SY; Sung JK; Jung JY; Grimm R; Son Y; Paek MY; Min CK; Ha KY
PLoS One; 2018; 13(12):e0208860. PubMed ID: 30557373
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of apparent diffusion coefficient thresholds for diagnosis of medulloblastoma using diffusion-weighted imaging.
Pierce TT; Provenzale JM
Neuroradiol J; 2014 Feb; 27(1):63-74. PubMed ID: 24571835
[TBL] [Abstract][Full Text] [Related]
47. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
[TBL] [Abstract][Full Text] [Related]
49. Differentiation of brain metastases originating from lung and breast cancers using apparent diffusion coefficient histogram analysis and the relation of histogram parameters with Ki-67.
Bozdağ M; Er A; Ekmekçi S
Neuroradiol J; 2022 Jun; 35(3):370-377. PubMed ID: 34609916
[TBL] [Abstract][Full Text] [Related]
50. Influence of menstrual status and pathological type on the apparent diffusion coefficient in cervical cancer: a primary study.
Dong Y; Dong RT; Zhang XM; Song QL; Yu T; Hong Luo Y
Acta Radiol; 2021 Mar; 62(3):430-436. PubMed ID: 32536261
[TBL] [Abstract][Full Text] [Related]
51. The diagnostic value of diffusion-weighted imaging and the apparent diffusion coefficient values in the differentiation of benign and malignant breast lesions.
Çabuk G; Nass Duce M; Özgür A; Apaydın FD; Polat A; Orekici G
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):141-8. PubMed ID: 25564776
[TBL] [Abstract][Full Text] [Related]
52. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
53. Meta-Analysis of Apparent Diffusion Coefficient in Pediatric Medulloblastoma, Ependymoma, and Pilocytic Astrocytoma.
Dury RJ; Lourdusamy A; Macarthur DC; Peet AC; Auer DP; Grundy RG; Dineen RA
J Magn Reson Imaging; 2022 Jul; 56(1):147-157. PubMed ID: 34842328
[TBL] [Abstract][Full Text] [Related]
54. Correlation Between Minimum Apparent Diffusion Coefficient (ADC
Surov A; Meyer HJ; Wienke A
Anticancer Res; 2017 Jul; 37(7):3807-3810. PubMed ID: 28668879
[TBL] [Abstract][Full Text] [Related]
55. Optimal b value in diffusion-weighted imaging for differentiation of abdominal lesions.
Koc Z; Erbay G
J Magn Reson Imaging; 2014 Sep; 40(3):559-66. PubMed ID: 24115207
[TBL] [Abstract][Full Text] [Related]
56. Diffusion magnetic resonance imaging for enhanced visualization of malignant cerebral tumors and abscesses.
Ohba S; Ushioda T; Nakagawa T; Shimizu K; Murakami H
Neurol India; 2011; 59(5):674-8. PubMed ID: 22019649
[TBL] [Abstract][Full Text] [Related]
57. Recurrent or symptomatic residual posterior fossa hemangioblastomas: how are they different from their primary counterparts?
Gupta S; Pal L; Sardhara JC; Jaiswal AK; Srivastava A; Mehrotra A; Das KK; Behari S
Acta Neurochir (Wien); 2017 Aug; 159(8):1497-1510. PubMed ID: 28601978
[TBL] [Abstract][Full Text] [Related]
58. Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma.
Li H; Liu XW; Geng ZJ; Wang DL; Xie CM
Dentomaxillofac Radiol; 2015; 44(3):20140126. PubMed ID: 25430557
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of combined visualization of MR diffusion and perfusion maps in glioblastoma.
Deike K; Wiestler B; Graf M; Reimer C; Floca RO; Bäumer P; Kickingereder P; Heiland S; Schlemmer HP; Wick W; Bendszus M; Radbruch A
J Neurooncol; 2016 Feb; 126(3):463-72. PubMed ID: 26518541
[TBL] [Abstract][Full Text] [Related]
60. Diffuse Cerebral Vasospasm After Removal of a Posterior Fossa Hemangioblastoma in a 62-Year-Old Woman.
Kinoshita Y; Sato K; Ito T; Nakamura H
World Neurosurg; 2020 Nov; 143():97-101. PubMed ID: 32730967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
